Select a community
All Communities
Home > Community Treatment Reports > Piroxicam Treatment Report
What is Piroxicam?

Piroxicam is a non-steroidal anti-inflammatory medication (NSAID) used to provide relief from pain, tenderness, swelling, and stiffness caused by osteoarthritis or rheumatoid arthritis. Read more...Click to read more below

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Stiffness/Spasticity 4 1
chronic pain 4 0
Other 2 1
Pain 2 0
Fibromyalgia 2 0
Osteoarthritis (OA) 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
1 50%
Moderate
0 0%
Mild
0 0%
None
1 50%

Most commonly reported side effects

Constipation
1 50%
  • Mild
  • Moderate
  • Severe

Dosages

  10 mg daily 20 daily 20 mg daily 30 mg daily
  3 Number of Patients: 3 1 Number of Patients: 1 8 Number of Patients: 8 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Piroxicam (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe
2 50% Side effects too severe: 50%
Other
2 50% Other: 50%
Did not seem to work
1 25% Did not seem to work: 25%
Doctor's advice
1 25% Doctor's advice: 25%

See all 4 patients who’ve stopped taking Piroxicam

Duration See details about how long patients take this treatment ▼

Currently Taking Piroxicam

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
2
1
4
1
1

Stopped Taking Piroxicam

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
2
0
1
0
0
1

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
1 50%
Usually
0 0%
Sometimes
1 50%
Never
0 0%

Burden

Difficulty being on treatment

Very
1 50%
Somewhat
0 0%
A little
0 0%
Not at all
1 50%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
2 100%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 23, 2009.